|
Pembrolizumab (+) Berahyaluronidase alfa Clinical Trials
1 actively recruiting trial across 1 location
Also known as: MK-3475A
Birmingham, Alabama1 trial
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Central Alabama Research ( Site 0108)
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.